My bookmarksSign up free

Council Regulation (EEC) No 4064/89 Article 3

Council Regulation (EEC) No 4064/89 Article 3

Article 3

This Decision is addressed to: Sanofi 174 avenue de France F - 75013 Paris Synthélabo 22 avenue de Galilée , BP 82 F - 92355 Le Plessis Robinson. Done at Brussels, 28 July 1999. For the Commission Karel Van Miert Member of the Commission (1) OJ L 395, 30.12.1989, p. 1; corrigendum OJ L 257, 21.9.1990, p. 13. (2) OJ L 180, 9.7.1997, p. 1; corrigendum OJ L 40, 13.2.1998, p. 17. (3) OJ L 61, 2.3.1998, p. 1; corrigendum OJ L 66, 6.3.1998, p. 25. (4) Parts of this text have been edited to ensure that confidential information is not disclosed; those parts are enclosed in square brackets and marked with an asterisk. (5) Parts of this text have been edited to ensure that confidential information is not disclosed; those parts are enclosed in square brackets and marked with an asterisk.

Read the full instrument →

Other provisions in Council Regulation (EEC) No 4064/89

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 3 of Council Regulation (EEC) No 4064/89 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next